Figure 1 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival

Figure 1 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival

<p>Knocking down SIRT3 caused ATF4 signaling inhibition but not HIF1a. <b>A,</b> Dendrograms from hierarchical clustering of RNA-seq data from three DLBCL cells lines transduced with lentiviruses containing control (scramble) or two SIRT3 shRNAs. <b>B,</b> Heatmap showi...

সম্পূর্ণ বিবরণ

সংরক্ষণ করুন:

গ্রন্থ-পঞ্জীর বিবরন
প্রধান লেখক:	Meng Li (79487) (author)
অন্যান্য লেখক:	Matthew R. Teater (15129060) (author), Jun Young Hong (6588914) (author), Noel R. Park (15129063) (author), Cihangir Duy (15112006) (author), Hao Shen (195461) (author), Ling Wang (56577) (author), Zhengming Chen (385056) (author), Leandro Cerchietti (15091552) (author), Shawn M. Davidson (14911596) (author), Hening Lin (1306563) (author), Ari M. Melnick (15110132) (author)
প্রকাশিত:	2025
বিষয়গুলি:	Cancer Molecular and Cellular Biology Cellular Stress Responses Gene Regulation Posttranscriptional and translational control Hematological Cancers Lymphomas Metabolism
ট্যাগগুলো:	ট্যাগ যুক্ত করুন কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!

অনুরূপ উপাদানগুলি

Figure 2 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
অনুযায়ী: Meng Li (79487)
প্রকাশিত: (2025)

Figure 3 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
অনুযায়ী: Meng Li (79487)
প্রকাশিত: (2025)

Figure 4 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
অনুযায়ী: Meng Li (79487)
প্রকাশিত: (2025)

Figure 5 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
অনুযায়ী: Meng Li (79487)
প্রকাশিত: (2025)

Figure 6 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
অনুযায়ী: Meng Li (79487)
প্রকাশিত: (2025)

Figure 7 from Translational Activation of ATF4 through Mitochondrial Anaplerotic Metabolic Pathways Is Required for DLBCL Growth and Survival
অনুযায়ী: Meng Li (79487)
প্রকাশিত: (2025)

Supplementary Table S3 from The Polyamine–Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in MYC-Driven Lymphoma
অনুযায়ী: Shima Nakanishi (16336496)
প্রকাশিত: (2025)

Supplementary Table S4 from The Polyamine–Hypusine Circuit Controls an Oncogenic Translational Program Essential for Malignant Conversion in MYC-Driven Lymphoma
অনুযায়ী: Shima Nakanishi (16336496)
প্রকাশিত: (2025)

Supplementary Tables from Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells
অনুযায়ী: Francesco Maura (15022226)
প্রকাশিত: (2025)

Table S1 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
অনুযায়ী: Yun-Guang Hong (14960966)
প্রকাশিত: (2025)

Table S2 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
অনুযায়ী: Yun-Guang Hong (14960966)
প্রকাশিত: (2025)

Table S3 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
অনুযায়ী: Yun-Guang Hong (14960966)
প্রকাশিত: (2025)

Table S4 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
অনুযায়ী: Yun-Guang Hong (14960966)
প্রকাশিত: (2025)

Table S5 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
অনুযায়ী: Yun-Guang Hong (14960966)
প্রকাশিত: (2025)

Table S6 from The RNA m<sup>6</sup>A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression
অনুযায়ী: Yun-Guang Hong (14960966)
প্রকাশিত: (2025)

Supplementary Table 1 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
অনুযায়ী: Duygu Kuzuoglu-Ozturk (14960213)
প্রকাশিত: (2025)

Supplementary Table 2 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
অনুযায়ী: Duygu Kuzuoglu-Ozturk (14960213)
প্রকাশিত: (2025)

Supplementary Table 3 from N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
অনুযায়ী: Duygu Kuzuoglu-Ozturk (14960213)
প্রকাশিত: (2025)

Supplementary Tables from The IGF2BP3–COPS7B Axis Facilitates mRNA Translation to Drive Colorectal Cancer Progression
অনুযায়ী: Jing Tang (17314958)
প্রকাশিত: (2025)

Supplementary Table S10 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
অনুযায়ী: Anfal Alsadhan (15907475)
প্রকাশিত: (2025)

Supplementary Table S4 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
অনুযায়ী: Anfal Alsadhan (15907475)
প্রকাশিত: (2025)

Supplementary Table S5 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
অনুযায়ী: Anfal Alsadhan (15907475)
প্রকাশিত: (2025)

Supplementary Table S6 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
অনুযায়ী: Anfal Alsadhan (15907475)
প্রকাশিত: (2025)

Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
অনুযায়ী: Anfal Alsadhan (15907475)
প্রকাশিত: (2025)

Supplementary Table S8 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
অনুযায়ী: Anfal Alsadhan (15907475)
প্রকাশিত: (2025)

Supplementary Table S9 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
অনুযায়ী: Anfal Alsadhan (15907475)
প্রকাশিত: (2025)

Supplementary Tables from Large B-cell Lymphomas of Immune-Privileged Sites Relapse via Parallel Clonal Evolution from a Common Progenitor B Cell
অনুযায়ী: G. Tjitske Los-de Vries (15618987)
প্রকাশিত: (2025)

Supplementary Tables S1-5 from METTL3-Mediated m<sup>6</sup>A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL
অনুযায়ী: Yiming Wu (15306005)
প্রকাশিত: (2025)

Supplementary Data S1 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
অনুযায়ী: Christopher T. Letson (16424095)
প্রকাশিত: (2025)

Supplementary Data S2 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
অনুযায়ী: Christopher T. Letson (16424095)
প্রকাশিত: (2025)

Supplementary Table S1 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
অনুযায়ী: Christopher T. Letson (16424095)
প্রকাশিত: (2025)

Supplementary Table S2 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
অনুযায়ী: Christopher T. Letson (16424095)
প্রকাশিত: (2025)

Supplementary Table S3 from Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML
অনুযায়ী: Christopher T. Letson (16424095)
প্রকাশিত: (2025)

Table S1 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
অনুযায়ী: Xun-Xi Lu (14952883)
প্রকাশিত: (2025)

Table S2 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
অনুযায়ী: Xun-Xi Lu (14952883)
প্রকাশিত: (2025)

Table S3 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
অনুযায়ী: Xun-Xi Lu (14952883)
প্রকাশিত: (2025)

Table S7 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
অনুযায়ী: Xun-Xi Lu (14952883)
প্রকাশিত: (2025)

Table S8 from An <i>In Vivo</i> CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression
অনুযায়ী: Xun-Xi Lu (14952883)
প্রকাশিত: (2025)

Table S2 from MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis
অনুযায়ী: Cheng-Kai Wang (14963880)
প্রকাশিত: (2025)

Supplementary table S5 from HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer
অনুযায়ী: Penglin Pan (14959703)
প্রকাশিত: (2025)

Cannot write session to /tmp/vufind_sessions/sess_ld0fo2ludfnu7tbsroaephmnlg